HIGHLIGHTS
- who: Marine Potez from the Arcellx Inc, United States Prince of Songkla University, Thailand have published the research: Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells, in the Journal: (JOURNAL)
- what: Tumor heterogeneity presently remains one of the main reasons for GBM resistance to treatment, largely due to the presence of cancer stem_cells. The authors employed peptides that were isolated from previous phage display biopanning with the aim of testing the hypothesis that these short synthetic peptides can be used as frontiersin.org 10.3389/fonc . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.